SCISP Sickle Cell & Thalassaemia Support Project Annual Report 2024-2025 00m CON Company No: 3575079 Charity No: 1077687 sctsp.org.uk f
Chairman's Remarks I want to take this opportunity to reflect on the achievements and challenges faced over the past financial year. We have successfully continued to provide services to meet the needs of the community, with an emphasis on outreach work, organising activities, and engaging directly with families. Despite the increasing challenges in the voluntary sector due to funding constraints, we have made continued difference to affected families and individuals. Collaboration with service providers at district and regional levels has been a key strategy to offer more structured and integrated services. I want express my gratitude and appreciation to all supporters for their valuable contributions. - Clarence Crosdale About Us The Sickle Cell & Thalassaemia Support Project (SCTSP) is a community organisation supporting individuals and families living with Sickle cell and Thalassaemia blood disorders across Wolverhampton, Walsall, Dudley and surrounding areas. We aim to: • Provide specialist information, advice and practical support • Deliver wellbeing and community activities that improve quality of life • Raise awareness among health professionals and the wider public • Empower families and young people to thrive despite the challenges of long-term conditions Our work includes direct one-to-one counselling as part of the NHS Sickle Cell & Thalassaemia Screening Programme, group activities and wider health and wellbeing programmes. Our Impact From April 2024 to March 2025, we received and processed 717 unusual blood results. Antenatal Neonatal Wolverhampton 202 134 Walsall 158 105 Dudley 118 To learn more about this process, please visit https://www.nhs.uk/pregnancy and search for screening for sickle. We have supported service users with their health plans and we have worked with schools to provide a new or reviewed care plan for children. We have also supported many affected adults, children and their families with their wellbeing through multiple activities and events. Number of Sickle Cell & Thalassaemia Clients: 165 Adults, 173 Children Areas of support: Wolverhampton, Walsall, Dudley and the surrounding areas. Finances NHS Contracts (70.6%) Income Breakdown 2024-25 Investments (10.2%) O Donations & Other (19.2%) Expenditure Breakdown 2024-25 General Overheads (11.4%) O Premises (5.9%)
Young Person & Family Engagement This year, we were proud to deliver a wide range of opportunities for young people to learn, connect and thrive. Our annual Sports Day featured football, archery and badminton, while our VR Workshops gave young people a chance to explore the world virtually and reflect on their experiences of NHS care. In February 2025 many families came together at our Move, Stretch & Dance Workshop, enjoying a day of movement and fun. Families also benefitted from special events such as the Collins Aerospace Family Fun Day, where children enjoyed rides, activities and face painting. "The kids had an absolute blast playing with other kids present and they can't stop talking about how much fun they had. Thank you all for having us."- Parent in Walsall Community Support & Keeping Warm In February 2025, we delivered the Winter Warm Project in partnership with National Grid and Act On Energy, distributing warm packs, conducting home visits and sharing practical advice on energy efficiency. At Christmas, we ran donation events in Wolverhampton and Walsall, distributing food, toiletries and children's clothing with the help of volunteers from Collins Aerospace. Families also received baby clothes, toys and home essentials throughout the winter to help them stay warm and well. "In general these items have not only met our immediate needs, but also brought a sense of security and hope. We are grateful and we thank you all for putting smiles on our faces."- Parent in Wolverhampton
Health & Wellbeing Support In November 2024, we launched our Wellbeing Support Programme, offering families free support directly from the project. This included: • Support to live a healthier lifestyle through nutrition, physical activity, mental wellbeing and sleep • Support for adults and young people to understand how to manage their emotions • Emotional regulation and coping strategies for children and young people Alongside this, our free massage service proved to be very popular with adults affected by Sickle cell, This was introduced following feedback at our AGM. Many patients found the sessions to be a great relief from pain and stress. Due to the popularity, we extended this programme through to March 2025. "I found the massage session extremely beneficial, especially for my stress levels, relaxation and also took away the awful headache, shoulder and neck pain/tension that I woke up with this morning"- Adult in Wolverhampton In December 2024, parents caring for children with Sickle Cell and Thalassaemia also benefitted from a Stress and Relaxation Workshop, where they were able to learn practical self-care tools and strategies. Shaping Healthcare Services We were commissioned by NHS England to carry out research into patient experiences of unplanned and emergency care. Through drop-in sessions, surveys and group events, we gathered meaningful insights that will help shape better care pathways nationally. In addition, opportunities were created for young people to have a direct influence on the future of healthcare through the planned Youth Forum at The Royal Wolverhampton NHS Trust. Alas "NOT ORDINARY PEOR Awareness & Advocacy In September 2024, we marked National Sickle Cell Awareness Month with educational talks, workplace training and a feature on #The VoiceBox radio show. During Black History Month in October 2024, we were proud to take part in events, including guest speaking at Holy Trinity Church and hosting our own event in Dudley, where families also received free Winter Warm Packs as part of the National Grid- Staying Warm This Winter project. Our specialist nurses and community counsellors represented the project in hospitals and community spaces throughout the year, including raising awareness at Walsall Manor Hospital. At the same time, we continued to engage with NHS England and wider research partners.
Partnerships & Fundraising Our work this year was strengthened by the generous contributions and involvement of our partners. Collins Aerospace supported us in numerous ways, inviting young people to their Olympics event, hosting STEM workshops, family days, and raising £1, 361 through the Tough Mudder Challenge. West Bromwich Building Society donated £600 towards our hardship fund and local fundraising during Black History Month also provided additional resources for families in need. National Grid also supported us to keep families warm and healthy through workshops and winter warm packs. The aim of this was to provide advice and essential items to keep homes warm and reduce the cost of energy bills. STEP REDEFINE ACTUATION Pay. I CELL AND SSAEMIA PROTECT € 1.36100 Signed EMERSCE ERd Acknowledgements We extend our gratitude to our staff, board members, volunteers, funders and community partners for their commitment and support. Most importantly, we thank the families we support. Your strength, resilience and feedback continue to inspire our work and shape everything we do. Our Supporters 3n Collins Aerospace nationalgrid Walsall Healthcare NHS NHS Trust Act
On
Energy INHS Dudley Integrated Health and Care NHS Trust Paycane THE NEW BLACK FILM COLLECTIVE NHS Black Country Integrated Care Board
COMPANY REGISTERED NUMBER: 03575079 (England and Wales) CHARITY REGISTERED NUMBER: 1077687 SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) REPORT OF THE DIRECTORS AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 Company Information Report of the Directors and Trustees Statement of Trustees' responsibilities Independent examiner's report Statement of financial activities Balance sheet Notes to the financial statements Page 1 2 4 5
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) COMPANY INFORMATION FOR THE YEAR ENDED 31ST MARCH 2025 DIRECTORS/TRUSTEES: SECRETARY: REGISTERED OFFICE: C R Crosdale D Mcintosh A Mcintos! Or D Kalri L Bell LT Mooruth DC Smith A A Ezomon S Herian Paycare House 1st Floor George Street Wolverhampton WV2 4DX 03575079 (England and Wales) REGISTERED NUMBER: REGISTERED CHARITY NUMBER: INDEPENDENT EXAMINER: BANKERS: SOLICITORS: 1077687 Neil Harris FCA BSc (Hons) Cygnet Accounting Limited 37 Rossell Driv Nottingham, NG9 TEC Lloyds Bank Plc 37 Queen Square Wolverhampton WV1 1TL Wall James Chappell 15-23 Hagley Road Stourbridge DY8 1QW Page 1
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2025 The directors, who are also trustees of the charity, present their report with the financial statements of the company for the year ended 31st March 2025. The directors have adopted the provisions of the Statement of Recommended Practice (SORP) "Accounting and Reporting by Charities" (FRS 102) in preparing the annual report and financial statements. PRINCIPAL ACTIVITIES The principal charitable activities of the company in the year under review were those to provide relief of poverty, sickness and distress, and enhancement of life, to those affected by the disorders Sickle Cell Disease and Thalassaemia, living within the West Midlands and surrounding areas. Those so affected are predominantly from African, Caribbean, Mediterranean and Asian communities. In 2016 the charity had expanded its activities to include working with families with complex and multiple needs, in order to promote, strengthen and improve their life chances. DIRECTORS AND TRUSTEES The directors and trustees during the year under review were: C R Crosdale D Mcintosh DA Mcintosh Dr D Kalra L Bell L T Mooruth D C Smith A A Ezomon COMPANY STATUS The company is limited by guarantee and is a registered charity (Registered No 1077687). This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. OBJECTS AND REVIEW OF THE COMPANY The report sets out activities and achievements of the charity for 2024/2025. The organisation was formed in September 1990 and founded as a charity in 1996. The objects of the charity allow the trustees to develop comprehensively and consistently high quality services for users, their carers, families and professionals who interact with them, within the Wolverhampton and surrounding areas notably Black Country and Staffordshire The Trustees support a number of activities in pursuant of its objects. These are as follows: • To offer counselling and screening to those individuals affected by Sickle Cell or Thalassaemia. To provide advice, support and guidance to affected individuals. To increase awareness by developing educational materials and promotion of raising awareness activities. To support both universal and voluntary screening programmes : To develop robust community development activities to promote and support the affected communities. • To strengthen and support families with complex and challenging needs. The Trustees meet every three months to review overall performance of the charity and to give strategic guidance. The directors/trustees review, and consider, the charitable company's reserves in the context of risks and funding. In setting a reserves policy the directors aim to establish reasonable but not absolute protection against risks and to balance this with the need to deploy resources in pursuit of the company's charitable objectives. Reserves are intended to: 1) Provide protection for most fluctuations in income and expenditure 2) Fund future investment needs and non-recurrent premises costs Operational Costs With the changes that have taken place during the year it has necessitated a review of the Reserve Policy in relation to operational activities. It is now proposed that the reserves target should at least cover eight months Page 2
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2025 of operation including redundancy cost. The new proposed figure is E225,000. The Reserves at the end of the financial year 2025 were £711,151 (2024: £733,112). Rent Costs SCTSP are currently residing in a building paying reduced service charge. This may not be a long-lasting agreement and we cannot be certain in anyway shape or form that the management structure of the owners of the building will not change and thereby begin to charge rent that will cause major disruption to the operational activities of SCTSP. With this in mind it is our proposal that we begin to build a reserve in the accounts to cater for this anomaly. We are currently paying service charge of about £9,750 per annum and we would expect that we probably should be paying rent somewhere in the region of £28,000 per annum. It is therefore proposed that in this year's accounts we set aside £48,000 in designated reserves. The majority of the charitable company's funding is from NHS contracts which normally are renewable on a 1- 2 year period. Additional funding is obtained from donations by supporters of the charity, however given the difficult economic climate, like many charities we have seen a reduction in this income, however we are still appreciative of those who continue to collect donations on behalf of the charity. We also recognise that those who make such donations are keen to see our service users directly benefit from their efforts and to this end the Trustees have decided that the majority of these funds will go towards the Hardship Fund established by the charity. Currently a provision of £5,000 has been set aside and will be drawn down within each year's expenditure depending on numbers of individuals identified to receive such support. The charity has invested surplus funds with the objective to generate funds through capital growth. The funds are managed by Milsted Langdon and are monitored by the Finance Sub Committee with regular reports to the Board. A cautious approach has been taken to risk over the period to reflect the volatility in the market that can occur. With the increase in income the organisation will review its investment portfolio with this in The Trustees regularly review the finances of the charity and are pleased that a satisfactory independent accountant's examination has been achieved. PUBLIC BENEFIT All the charity's activities are aimed at supporting local individuals affected by sickle cell and thalassaemia and families experiencing challenges. In developing activities and delivering services, the directors have taken account of the guidance published by the Charity Commission on public benefit. DEFINED BENEFIT PENSION SCHEME A full actuarial valuation was carried out as at 31 March 2022, the results of which are shown in note 9 of the financial statements. With respect to this liability Wolverhampton City Council has agreed to act as a guarantor towards this liability. However, the recent actuarial valuation, which shows a current liability of £512,000; as with previous years, the Trustees will continue to be mindful of this liability within its overall reserve policy. RISK MANAGEMENT The trustees have considered the major risks the charity faces. The charity's system of internal controls is designed to provide reasonable but not absolute assurance against misstatement or loss. The trustees are satisfied that the systems in place mitigate the charity's exposure to the major risks. ON BEHALF OF THE BOARD: mDel C R Crosdale - Director/Trustee Date: 23/9/2025 The notes form part of these financial statements Page 3
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31ST MARCH 2025 The trustees, who are also the directors of Sickle Cell and Thalassaemia Support Project (Wolverhampton) for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company Law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year. In preparing these financial statements, the trustees are required to: - select suitable accounting policies and then apply them consistently; - observe the methods and principles in the Charities SORP; - make judgements and estimates that are reasonable and prudent; - state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation. The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The notes form part of these financial statements Page 4
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31ST MARCH 2025 I report to the trustees on my examination of the financial statements of Sickle Cell And Thalassaemia Support Project (Wolverhampton) (the charity) for the year ended 31 March 2025. Responsibilities and basis of report As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act). Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, 1 report in respect of my examination of the charity's financial statements carried out under the Charities Act (the Act). In carrying out my examination have followed all the applicable Directions given by the Charity Commission under the Act Independent examiner's statement I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; 2 3 the financial statements do not accord with those records; or the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 4. the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. Neil Harris FCA BSc (Hons) Cygnet Accounting Limited 37 Rossell Drive Stapleford Nottingham NG9 7EG Dated: 21.02025• The notes form part of these financial statements Page 5
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31ST MARCH 2025 Unrestricted Restricted Funds Funds Notes Total Funds 2025 € INCOME FROM: Donations and other income Investment income Charitable activities: Service level agreements from: Black Country ICB Wolverhampton Place Black Country ICB Dudley Place Walsall Healthcare NHS Trust TOTAL INCOME EXPENDITURE ON: Raising funds Charitable activities 1 2 TOTAL EXPENDITURE Net incoming / (expenditure) before gain or loss on investments Unrealised gain/(loss) on investments Balances brought forward as at 1 April 2024 Balances carried forward as at 31 March 2025 50,164 26,735 76,899 300 7,243 7,543 69,356 1,872 535,143 606.371 : 50,164 26,735 116,414 17,065 51.142 184.621 116,414 17,065 51,142 261,520 13,086 264,724 277,810 (93,189) 13,386 271,967 285,353 (23,833) - 197.969 104,780 1,872 733,112 711,151 Total Funds 2024 90,001 18,593 115,720 16,962 50,773 292,049 10,981 230,534 241,515 50,534 4,317 678.261 733.112 The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006. The notes form part of these financial statements Page 6
1 2 SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2025 Total Unrestricted Restricted Funds Funds Funds 2025 € Total Funds 2024 RAISING FUNDS Wages Social Security Pensions Repairs & maintenance Telephone Sundry expenses Postage, printing & stationery Rent & service charge Insurance Depreciation - office equipmen Bank charge: 193 15 28 24 - 300 4 91 13,086 4 13,386 4 10.981 CHARITABLE ACTIVITIES Wages Social Security Pensions Staff training Travelling Repairs & maintenance Social hardship donation Social support Consultancy service development Subscriptions Telephone Sundry expenses Postage, printing & stationery Rent & service charge Insurance Depreciation - office equipment Support costs: Board expenses Accountancy Professional fees 1,832 283 537 - 75 182 811 - - 2,180 128 143 153 179 66 20 77 573 7,243 181,406 13,854 26,331 300 1,434 3,463 1,245 - 6,266 2,713 2,899 8,770 3,238 68 382 1,473 10.882 264,724 183,238 14,137 26,868 300 1,509 3,645 811 - 1,245 2,180 6,394 2,856 3,052 8,949 3,304 72 1.000 11,455 271.967 85 230.534 The notes form part of these financial statements Page 7
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) BALANCE SHEET 31ST MARCH 2025 2025 2024 Fixed assets Tangible assets Current assets Debtors Investments Cash at bank and in hand Creditors: Amounts falling due within one year Net current assets Total assets less current liabilities Creditors: Amounts falling due within one year Net assets Notes 4 € 428 7 12,910 54,796 729,567 797,273 (1,550) 795,723 796,151 8 85,000 711,151 € € 504 7,190 52,924 760,334 820,448 (2,840) 817,608 818,112 85,000 733,112 Income funds Unrestricted funds: General funds Designated funds Restricted funds Total income funds 526,371 80,000 606,371 104,780 711,151 455,143 80,000 535,143 197,969 733,112 The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2025. To decion export do at respond tea to mean in the regun al or ta mean it. The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2025 in accordance with Section 476 of the Companies Act 2006. These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved by the Board of Trustees on .and were signed on its behalf by: c R Crosdale Director/Trustee Company registration number 03575079 Page 8
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 1. Accounting policies Charity information Sickle Cell and Thalassaemia Support Project (Wolverhampton) is a private company limited by guarantee incorporated in England and Wales. The registered office is Paycare House, 1st Floor, George Street, Wolverhampton, WV2 4DX. The members of the company are the trustees names on page 1. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. Accounting convention The financial statements have been prepared under the historical cost convention and in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", the Charities Act, the Companies Act 2006 and the Statement of Recommended Practice: "Accounting and Reporting by Charities" (FRS 102) with the exception of accounting for the deficit on the defined benefit pension scheme, for which provision has been made as set out below and in note 9. The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £. Charitable funds objectives. Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable Designated funds comprise unrestricted funds that have been set aside by the trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements. Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. Income Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. Gifts in kind donated for distribution are included at valuation and recognised as income when they are distributed to the projects. Gifts donated for resale are included as income when they are sold. Donated facilities are included at the value to the charity where this can be quantified and a third party is bearing the cost. No amounts are included in the financial statements for services donated by volunteers. Expenditure Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset's use. Page 9
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 1. Accounting policies (continued) All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Where costs cannot by directly attributed to particular headings they have been allocated to activities on a basis consistent with use of the resources. Fund-raising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are costs incurred directly in support of expenditure on the objects of the charity and include project management carried out at headquarters. Management and administration costs are those incurred in connection with the administration of the charity and compliance with constitutional and statutory requirements. Tangible fixed assets Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: Plant and machinery Fixtures and fittings - 25% on cost - 15% & 25% on reducing balance The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities. Investments Investments are stated at market value at the balance sheet date. The SOFA includes the net gains or losses arising on revaluation throughout the year. Pensions The company operates a defined benefit pension scheme which provides benefits based on final pensionable pay. The scheme is administered by the West Midlands Pension Fund, and the assets are held independently of the finances of the company. The most recent full actuarial valuation was carried out at 31 March 2022. The projected valuation deficit in the scheme at 31 March 2022 was E512,000 the Board has considered this situation and feels that because of the age of the work force this deficit can be eliminated over a period of time and currently a total provision of £85,000 has been made to date in these accounts. Restricted Funds Monies received as grants for particular purposes are held as separate funds and are credited to the Statement of Financial Activities when costs of the particular relevant projects are incurred. Leases Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease. Page 10
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 2. STAFF COSTS Wages and salaries Social security costs Other pension costs 2025 € 192,882 14,881 28,282 236,045 The average monthly number of employees during the year was as follows: 2025 2024 156,890 9,663 23.724 190,277 2024 Charitable Workers ne employee (2024: nil) received total emoluments of more than £60,000 but less than £70,000. N mployees (2024: nil) received total emoluments above £70,000 OPERATING PROFIT/(LOSS) 2024 Depreciation - owned assets Directors' emoluments and other benefits etc 76 - 89 4. TANGIBLE FIXED ASSETS Cost At 1st April 2024 Additions Disposals At 31st March 2025 epreciatio t 1st April 202 Charge for year Eliminated on disposals At 31st March 2025 Net book value At 31st March 2025 At 31st March 2024 Plant and machinery € 23,824 23,824 23,824 23,824 Fixtures and fittings 13,391 13,391 12,887 76 12,963 428 504 Total € 37.215 37,215 36,711 76 36,787 428 504 Page 11
5. 6. 8. 9. SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Prepayments and accrued income 2025 € 12,910 2024 7,190 CURRENT ASSET INVESTMENTS Architas MA Passive Moderate S Acc 2025 € 54,796 2024 52,924 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Social security and other tax Accruals and deferred income 2025 € 1,550 1,550 2024 € 2840 2,840 CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR Provision for defined pension scheme deficit (see note 9) 2025 85,000 2024 85,000 PENSION SCHEME Value of scheme assets and liabilities Market value of assets Present value of scheme liabilities Pension scheme deficit 2025 € 2024 820,000 820,000 (1,332,000) (1,332.000) (512,000) (512,000) The above is based on a valuation at 31 March 2022. Provision of £85,000 has been made towards the above deficit. Page 12
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 10. OPERATING LEASE COMMITMENTS At the reporting end date the charity had outstanding commitments for future minimum lease payment. under non-cancellable operating leases, which fall due as follows 2025 2024 Within one year Between two and five years 11. ANALYSIS OF NET ASSETS BETWEEN FUNDS Fixed Assets Unrestricted Funds: eneral Fund esignated Fund Restricted Funds 428 428 Other Net Assets 526,371 80,000 606,371 104,352 710,723 Total Net Assets 526,371 80,000 606,371 104,780 711,151 12. RESTRICTED FUNDS Fund Black Country ICB Wolverhampton Place Purpose of Fund Reason for Restriction Support the antenatal and newborn screening Wolverhampton residents programme and provide counselling and support to those affected Black Country ICE Dudley Place Support affected children with long term Dudley residents only conditions to manage their condition through various social and community interventions Valsall Healthcare NHS Trust Support the antenatal and newborn screeni Walsall residents only rogramme and provide counselling ar support to those affected Page 13
COMPANY REGISTERED NUMBER: 03575079 (England and Wales) CHARITY REGISTERED NUMBER: 1077687 SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) REPORT OF THE DIRECTORS AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 Company Information Report of the Directors and Trustees Statement of Trustees' responsibilities Independent examiner's report Statement of financial activities Balance sheet Notes to the financial statements Page 1 2 4 5
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) COMPANY INFORMATION FOR THE YEAR ENDED 31ST MARCH 2025 DIRECTORS/TRUSTEES: SECRETARY: REGISTERED OFFICE: C R Crosdale D Mcintosh A Mcintos! Or D Kalri L Bell LT Mooruth DC Smith A A Ezomon S Herian Paycare House 1st Floor George Street Wolverhampton WV2 4DX 03575079 (England and Wales) REGISTERED NUMBER: REGISTERED CHARITY NUMBER: INDEPENDENT EXAMINER: BANKERS: SOLICITORS: 1077687 Neil Harris FCA BSc (Hons) Cygnet Accounting Limited 37 Rossell Driv Nottingham, NG9 TEC Lloyds Bank Plc 37 Queen Square Wolverhampton WV1 1TL Wall James Chappell 15-23 Hagley Road Stourbridge DY8 1QW Page 1
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2025 The directors, who are also trustees of the charity, present their report with the financial statements of the company for the year ended 31st March 2025. The directors have adopted the provisions of the Statement of Recommended Practice (SORP) "Accounting and Reporting by Charities" (FRS 102) in preparing the annual report and financial statements. PRINCIPAL ACTIVITIES The principal charitable activities of the company in the year under review were those to provide relief of poverty, sickness and distress, and enhancement of life, to those affected by the disorders Sickle Cell Disease and Thalassaemia, living within the West Midlands and surrounding areas. Those so affected are predominantly from African, Caribbean, Mediterranean and Asian communities. In 2016 the charity had expanded its activities to include working with families with complex and multiple needs, in order to promote, strengthen and improve their life chances. DIRECTORS AND TRUSTEES The directors and trustees during the year under review were: C R Crosdale D Mcintosh DA Mcintosh Dr D Kalra L Bell L T Mooruth D C Smith A A Ezomon COMPANY STATUS The company is limited by guarantee and is a registered charity (Registered No 1077687). This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. OBJECTS AND REVIEW OF THE COMPANY The report sets out activities and achievements of the charity for 2024/2025. The organisation was formed in September 1990 and founded as a charity in 1996. The objects of the charity allow the trustees to develop comprehensively and consistently high quality services for users, their carers, families and professionals who interact with them, within the Wolverhampton and surrounding areas notably Black Country and Staffordshire The Trustees support a number of activities in pursuant of its objects. These are as follows: • To offer counselling and screening to those individuals affected by Sickle Cell or Thalassaemia. To provide advice, support and guidance to affected individuals. To increase awareness by developing educational materials and promotion of raising awareness activities. To support both universal and voluntary screening programmes : To develop robust community development activities to promote and support the affected communities. • To strengthen and support families with complex and challenging needs. The Trustees meet every three months to review overall performance of the charity and to give strategic guidance. The directors/trustees review, and consider, the charitable company's reserves in the context of risks and funding. In setting a reserves policy the directors aim to establish reasonable but not absolute protection against risks and to balance this with the need to deploy resources in pursuit of the company's charitable objectives. Reserves are intended to: 1) Provide protection for most fluctuations in income and expenditure 2) Fund future investment needs and non-recurrent premises costs Operational Costs With the changes that have taken place during the year it has necessitated a review of the Reserve Policy in relation to operational activities. It is now proposed that the reserves target should at least cover eight months Page 2
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) REPORT OF THE DIRECTORS AND TRUSTEES FOR THE YEAR ENDED 31ST MARCH 2025 of operation including redundancy cost. The new proposed figure is E225,000. The Reserves at the end of the financial year 2025 were £711,151 (2024: £733,112). Rent Costs SCTSP are currently residing in a building paying reduced service charge. This may not be a long-lasting agreement and we cannot be certain in anyway shape or form that the management structure of the owners of the building will not change and thereby begin to charge rent that will cause major disruption to the operational activities of SCTSP. With this in mind it is our proposal that we begin to build a reserve in the accounts to cater for this anomaly. We are currently paying service charge of about £9,750 per annum and we would expect that we probably should be paying rent somewhere in the region of £28,000 per annum. It is therefore proposed that in this year's accounts we set aside £48,000 in designated reserves. The majority of the charitable company's funding is from NHS contracts which normally are renewable on a 1- 2 year period. Additional funding is obtained from donations by supporters of the charity, however given the difficult economic climate, like many charities we have seen a reduction in this income, however we are still appreciative of those who continue to collect donations on behalf of the charity. We also recognise that those who make such donations are keen to see our service users directly benefit from their efforts and to this end the Trustees have decided that the majority of these funds will go towards the Hardship Fund established by the charity. Currently a provision of £5,000 has been set aside and will be drawn down within each year's expenditure depending on numbers of individuals identified to receive such support. The charity has invested surplus funds with the objective to generate funds through capital growth. The funds are managed by Milsted Langdon and are monitored by the Finance Sub Committee with regular reports to the Board. A cautious approach has been taken to risk over the period to reflect the volatility in the market that can occur. With the increase in income the organisation will review its investment portfolio with this in The Trustees regularly review the finances of the charity and are pleased that a satisfactory independent accountant's examination has been achieved. PUBLIC BENEFIT All the charity's activities are aimed at supporting local individuals affected by sickle cell and thalassaemia and families experiencing challenges. In developing activities and delivering services, the directors have taken account of the guidance published by the Charity Commission on public benefit. DEFINED BENEFIT PENSION SCHEME A full actuarial valuation was carried out as at 31 March 2022, the results of which are shown in note 9 of the financial statements. With respect to this liability Wolverhampton City Council has agreed to act as a guarantor towards this liability. However, the recent actuarial valuation, which shows a current liability of £512,000; as with previous years, the Trustees will continue to be mindful of this liability within its overall reserve policy. RISK MANAGEMENT The trustees have considered the major risks the charity faces. The charity's system of internal controls is designed to provide reasonable but not absolute assurance against misstatement or loss. The trustees are satisfied that the systems in place mitigate the charity's exposure to the major risks. ON BEHALF OF THE BOARD: mDel C R Crosdale - Director/Trustee Date: 23/9/2025 The notes form part of these financial statements Page 3
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) STATEMENT OF TRUSTEES' RESPONSIBILITIES FOR THE YEAR ENDED 31ST MARCH 2025 The trustees, who are also the directors of Sickle Cell and Thalassaemia Support Project (Wolverhampton) for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company Law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year. In preparing these financial statements, the trustees are required to: - select suitable accounting policies and then apply them consistently; - observe the methods and principles in the Charities SORP; - make judgements and estimates that are reasonable and prudent; - state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation. The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The notes form part of these financial statements Page 4
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31ST MARCH 2025 I report to the trustees on my examination of the financial statements of Sickle Cell And Thalassaemia Support Project (Wolverhampton) (the charity) for the year ended 31 March 2025. Responsibilities and basis of report As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act). Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, 1 report in respect of my examination of the charity's financial statements carried out under the Charities Act (the Act). In carrying out my examination have followed all the applicable Directions given by the Charity Commission under the Act Independent examiner's statement I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; 2 3 the financial statements do not accord with those records; or the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 4. the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. Neil Harris FCA BSc (Hons) Cygnet Accounting Limited 37 Rossell Drive Stapleford Nottingham NG9 7EG Dated: 21.02025• The notes form part of these financial statements Page 5
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31ST MARCH 2025 Unrestricted Restricted Funds Funds Notes Total Funds 2025 € INCOME FROM: Donations and other income Investment income Charitable activities: Service level agreements from: Black Country ICB Wolverhampton Place Black Country ICB Dudley Place Walsall Healthcare NHS Trust TOTAL INCOME EXPENDITURE ON: Raising funds Charitable activities 1 2 TOTAL EXPENDITURE Net incoming / (expenditure) before gain or loss on investments Unrealised gain/(loss) on investments Balances brought forward as at 1 April 2024 Balances carried forward as at 31 March 2025 50,164 26,735 76,899 300 7,243 7,543 69,356 1,872 535,143 606.371 : 50,164 26,735 116,414 17,065 51.142 184.621 116,414 17,065 51,142 261,520 13,086 264,724 277,810 (93,189) 13,386 271,967 285,353 (23,833) - 197.969 104,780 1,872 733,112 711,151 Total Funds 2024 90,001 18,593 115,720 16,962 50,773 292,049 10,981 230,534 241,515 50,534 4,317 678.261 733.112 The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006. The notes form part of these financial statements Page 6
1 2 SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST MARCH 2025 Total Unrestricted Restricted Funds Funds Funds 2025 € Total Funds 2024 RAISING FUNDS Wages Social Security Pensions Repairs & maintenance Telephone Sundry expenses Postage, printing & stationery Rent & service charge Insurance Depreciation - office equipmen Bank charge: 193 15 28 24 - 300 4 91 13,086 4 13,386 4 10.981 CHARITABLE ACTIVITIES Wages Social Security Pensions Staff training Travelling Repairs & maintenance Social hardship donation Social support Consultancy service development Subscriptions Telephone Sundry expenses Postage, printing & stationery Rent & service charge Insurance Depreciation - office equipment Support costs: Board expenses Accountancy Professional fees 1,832 283 537 - 75 182 811 - - 2,180 128 143 153 179 66 20 77 573 7,243 181,406 13,854 26,331 300 1,434 3,463 1,245 - 6,266 2,713 2,899 8,770 3,238 68 382 1,473 10.882 264,724 183,238 14,137 26,868 300 1,509 3,645 811 - 1,245 2,180 6,394 2,856 3,052 8,949 3,304 72 1.000 11,455 271.967 85 230.534 The notes form part of these financial statements Page 7
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) BALANCE SHEET 31ST MARCH 2025 2025 2024 Fixed assets Tangible assets Current assets Debtors Investments Cash at bank and in hand Creditors: Amounts falling due within one year Net current assets Total assets less current liabilities Creditors: Amounts falling due within one year Net assets Notes 4 € 428 7 12,910 54,796 729,567 797,273 (1,550) 795,723 796,151 8 85,000 711,151 € € 504 7,190 52,924 760,334 820,448 (2,840) 817,608 818,112 85,000 733,112 Income funds Unrestricted funds: General funds Designated funds Restricted funds Total income funds 526,371 80,000 606,371 104,780 711,151 455,143 80,000 535,143 197,969 733,112 The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2025. To decion export do at respond tea to mean in the regun al or ta mean it. The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2025 in accordance with Section 476 of the Companies Act 2006. These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved by the Board of Trustees on .and were signed on its behalf by: c R Crosdale Director/Trustee Company registration number 03575079 Page 8
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 1. Accounting policies Charity information Sickle Cell and Thalassaemia Support Project (Wolverhampton) is a private company limited by guarantee incorporated in England and Wales. The registered office is Paycare House, 1st Floor, George Street, Wolverhampton, WV2 4DX. The members of the company are the trustees names on page 1. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. Accounting convention The financial statements have been prepared under the historical cost convention and in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", the Charities Act, the Companies Act 2006 and the Statement of Recommended Practice: "Accounting and Reporting by Charities" (FRS 102) with the exception of accounting for the deficit on the defined benefit pension scheme, for which provision has been made as set out below and in note 9. The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £. Charitable funds objectives. Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable Designated funds comprise unrestricted funds that have been set aside by the trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements. Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. Income Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. Gifts in kind donated for distribution are included at valuation and recognised as income when they are distributed to the projects. Gifts donated for resale are included as income when they are sold. Donated facilities are included at the value to the charity where this can be quantified and a third party is bearing the cost. No amounts are included in the financial statements for services donated by volunteers. Expenditure Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset's use. Page 9
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 1. Accounting policies (continued) All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all costs related to the category. Where costs cannot by directly attributed to particular headings they have been allocated to activities on a basis consistent with use of the resources. Fund-raising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are costs incurred directly in support of expenditure on the objects of the charity and include project management carried out at headquarters. Management and administration costs are those incurred in connection with the administration of the charity and compliance with constitutional and statutory requirements. Tangible fixed assets Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: Plant and machinery Fixtures and fittings - 25% on cost - 15% & 25% on reducing balance The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities. Investments Investments are stated at market value at the balance sheet date. The SOFA includes the net gains or losses arising on revaluation throughout the year. Pensions The company operates a defined benefit pension scheme which provides benefits based on final pensionable pay. The scheme is administered by the West Midlands Pension Fund, and the assets are held independently of the finances of the company. The most recent full actuarial valuation was carried out at 31 March 2022. The projected valuation deficit in the scheme at 31 March 2022 was E512,000 the Board has considered this situation and feels that because of the age of the work force this deficit can be eliminated over a period of time and currently a total provision of £85,000 has been made to date in these accounts. Restricted Funds Monies received as grants for particular purposes are held as separate funds and are credited to the Statement of Financial Activities when costs of the particular relevant projects are incurred. Leases Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease. Page 10
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 2. STAFF COSTS Wages and salaries Social security costs Other pension costs 2025 € 192,882 14,881 28,282 236,045 The average monthly number of employees during the year was as follows: 2025 2024 156,890 9,663 23.724 190,277 2024 Charitable Workers ne employee (2024: nil) received total emoluments of more than £60,000 but less than £70,000. N mployees (2024: nil) received total emoluments above £70,000 OPERATING PROFIT/(LOSS) 2024 Depreciation - owned assets Directors' emoluments and other benefits etc 76 - 89 4. TANGIBLE FIXED ASSETS Cost At 1st April 2024 Additions Disposals At 31st March 2025 epreciatio t 1st April 202 Charge for year Eliminated on disposals At 31st March 2025 Net book value At 31st March 2025 At 31st March 2024 Plant and machinery € 23,824 23,824 23,824 23,824 Fixtures and fittings 13,391 13,391 12,887 76 12,963 428 504 Total € 37.215 37,215 36,711 76 36,787 428 504 Page 11
5. 6. 8. 9. SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Prepayments and accrued income 2025 € 12,910 2024 7,190 CURRENT ASSET INVESTMENTS Architas MA Passive Moderate S Acc 2025 € 54,796 2024 52,924 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Social security and other tax Accruals and deferred income 2025 € 1,550 1,550 2024 € 2840 2,840 CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR Provision for defined pension scheme deficit (see note 9) 2025 85,000 2024 85,000 PENSION SCHEME Value of scheme assets and liabilities Market value of assets Present value of scheme liabilities Pension scheme deficit 2025 € 2024 820,000 820,000 (1,332,000) (1,332.000) (512,000) (512,000) The above is based on a valuation at 31 March 2022. Provision of £85,000 has been made towards the above deficit. Page 12
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2025 10. OPERATING LEASE COMMITMENTS At the reporting end date the charity had outstanding commitments for future minimum lease payment. under non-cancellable operating leases, which fall due as follows 2025 2024 Within one year Between two and five years 11. ANALYSIS OF NET ASSETS BETWEEN FUNDS Fixed Assets Unrestricted Funds: eneral Fund esignated Fund Restricted Funds 428 428 Other Net Assets 526,371 80,000 606,371 104,352 710,723 Total Net Assets 526,371 80,000 606,371 104,780 711,151 12. RESTRICTED FUNDS Fund Black Country ICB Wolverhampton Place Purpose of Fund Reason for Restriction Support the antenatal and newborn screening Wolverhampton residents programme and provide counselling and support to those affected Black Country ICE Dudley Place Support affected children with long term Dudley residents only conditions to manage their condition through various social and community interventions Valsall Healthcare NHS Trust Support the antenatal and newborn screeni Walsall residents only rogramme and provide counselling ar support to those affected Page 13